Ajay Samkaria/LinkedIn
Jun 9, 2026, 17:53
Ajay Samkaria: How ABO Subgroups Directly Impact Transfusion Safety
Ajay Samkaria, Product and Application Manager at DIAGAST, shared a post on LinkedIn:
“ABO subgroups are more than just laboratory curiosities—they are clinically significant and can directly impact transfusion safety.
Weak or variant antigen expressions may lead to blood grouping discrepancies, incompatible transfusions, and delayed clinical decisions if not properly identified.
Highlights:
- Classification of A, B and O subgroups.
- Bombay (Oh) and Para Bombay phenotypes.
- Rare phenotypes such as INA and INB.
- Clinical and immunohematological significance.
- Common methods for subgroup confirmation.
Accurate detection and confirmation of ABO subgroups remain essential for safe transfusion practice and quality immunohematology reporting.”
Stay updated with Hemostasis Today.
-
Jul 18, 2026, 14:30Denise Rezende: Werfen Reflects on a Successful ISTH 2026 Congress
-
Jul 18, 2026, 14:28Isabelle Salles-Crawley: Science, Collaboration, and Inspiration at ISTH 2026
-
Jul 18, 2026, 14:05Habib Bennaceur: Novo Nordisk Highlights Progress in Rare Bleeding Disorders at ISTH 2026
-
Jul 18, 2026, 13:56C. Heleen van Ommen: IPTN Meeting Highlights Progress in Pediatric Thrombosis
-
Jul 18, 2026, 13:42Chokri Ben Lamine: Optimizing PBSC Donation in Hemoglobinopathy Carriers
-
Jul 18, 2026, 12:17Doruntina Lahu: Prasugrel and Ticagrelor – Does Sex Matter?
-
Jul 18, 2026, 11:54Paul Riley: Presenting STAR Max3 at ISTH 2026
-
Jul 18, 2026, 11:38Abdul Mannan: Normal Blood DEB Test Does Not Always Rule Out Fanconi Anaemia
-
Jul 18, 2026, 10:47Adela Perolla: Lighting the Flame for Future Hematologists